跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEMGESIC SUBLINGUAL TABLET 0.2 mg - HSA Drug Approval Details
Approvals
/
HSA
/
TEMGESIC SUBLINGUAL TABLET 0.2 mg
Approved
THERAPEUTIC
TEMGESIC SUBLINGUAL TABLET 0.2 mg
RECKITT BENCKISER HEALTHCARE (UK) LTD
🇸🇬 Health Sciences Authority
Approval Date
May 17, 1991
Approval ID
050fc33397484083
Company
RECKITT BENCKISER HEALTHCARE (UK) LTD
Type
Therapeutic
Approval Details
Approval Id
050fc33397484083
Drug Name
TEMGESIC SUBLINGUAL TABLET 0.2 mg
Product Name
TEMGESIC SUBLINGUAL TABLET 0.2 mg
Approval Number
SIN06115P
Approval Date
1991-05-17
Registrant
ZUELLIG PHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
N02AE01
Atc Item Name
buprenorphine
Pharma Manufacturer Name
ZUELLIG PHARMA PTE. LTD.
Company Detail Path
/organization/zuellig-pharma-pte-ltd
Active Ingredients
BUPRENORPHINE HCl EQV BUPRENORPHINE
0.2 mg
BUPRENORPHINE HCl EQV BUPRENORPHINE
0.2 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 17, 1991
Approval ID
050fc33397484083
Type
Therapeutic
Back to HSA Approvals